A safety assessment of the iZephyr Hood for patients receiving NIV

  • Research type

    Research Study

  • Full title

    Suitability of an aerosol removing device (iZephyr hood) for COVID-19 patients using non-invasive ventilation or high flow oxygen therapy

  • IRAS ID

    292573

  • Contact name

    Neil Tolley

  • Contact email

    neil.tolley@nhs.net

  • Sponsor organisation

    Imperial College, London

  • Clinicaltrials.gov Identifier

    NCT04904484

  • Duration of Study in the UK

    0 years, 6 months, 10 days

  • Research summary

    Patients with Covid-19 requiring support with their breathing in hospital will have non-invasive ventilation or high flow oxygen using a device called optiflow. These methods of helping the patient to breathe have been shown to spread aerosols which pose a significant health risk to members of staff and to other patients in the hospital.

    In some instances, there has been lack of access to the recommended personal protective equipment, making looking after these patients these extremely unsafe for the staff caring for these patients.

    One way to reduce the risk to the health care staff and to other patients in the hospital, particularly other patients on the same hospital ward, is to provide an aerosol shielding device to fit around the patient. There have been a number of shielding devices trialled across the country, including perspex boxes and plastic sheeting, however these have proven to be cumbersome, difficult to disinfect after use and in some cases may lead to an increase in aerosol spread due to poor design.

    Our team, made up of team members from Imperial College Healthcare NHS Trust, Imperial College and Mercedes F1 design team, have collaborated and designed an aerosol shielding device This is a lightweight aerosol shielding device with a low power vacuum extraction system. The entry ports have been designed to give maximum access to the patient and their airway to allow multiple potential uses. The use we would like to research is for use in COVID-19 positive patients having non-invasive ventilation or high flow oxygen therapy in the hospital setting.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    21/NW/0080

  • Date of REC Opinion

    27 May 2021

  • REC opinion

    Further Information Favourable Opinion